Chronic intermittent hypoxia leads to insulin resistance and impaired glucose tolerance through dysregulation of adipokines in non-obese rats

Sleep and Breathing

Volumn 19, Issue 4, 2015, Pages 1467-1473

  Fu, Cuiping ^a   Jiang, Liyan ^b   Zhu, Fen ^a   Liu, Zilong ^a   Li, Wenjing ^a   Jiang, Hong ^a   Ye, Hongying ^c   Kushida, Clete A ^d   Li, Shanqun ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d STANFORD UNIVERSITY   (United States)

Author keywords

Adipokine; Chronic intermittent hypoxia; Impaired glucose tolerance; Insulin resistance; Sleep apnea

Indexed keywords

ADIPONECTIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTATE DEHYDROGENASE; LEPTIN; MESSENGER RNA; OXYGEN; RESISTIN; ADIPOCYTOKINE; GLUCOSE BLOOD LEVEL; INSULIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BLOOD; CALCULATION; CHRONIC INTERMITTENT HYPOXIA; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE TOLERANCE; HYPOXEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CHRONIC DISEASE; DISEASE MODEL; GLUCOSE BLOOD LEVEL; HYPOXIA; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE;

ADIPOKINES; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYPOXIA; INSULIN; INSULIN RESISTANCE; MALE; RATS; REFERENCE VALUES;

EID: 84949092427     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-015-1144-8     Document Type: Article

References (29)

1. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165(5):670–676. doi:10.1164/ajrccm.165.5.2103001
2. Robinson GV, Stradling JR, Davies RJ (2004) Sleep. 6: obstructive sleep apnoea/hypopnoea syndrome and hypertension. Thorax 59(12):1089–1094. doi:10.1136/thx.2003.015875
3. Vatansever E, Surmen-Gur E, Ursavas A, Karadag M (2011) Obstructive sleep apnea causes oxidative damage to plasma lipids and proteins and decreases adiponectin levels. Sleep Breath 15(3):275–282. doi:10.1007/s11325-010-0378-8
4. Iiyori N, Alonso LC, Li J, Sanders MH, Garcia-Ocana A, O'Doherty RM, Polotsky VY, O'Donnell CP (2007) Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 175(8):851–857. doi:10.1164/rccm.200610-1527OC
5. Muraki I, Tanigawa T, Yamagishi K, Sakurai S, Ohira T, Imano H, Kitamura A, Kiyama M, Sato S, Shimamoto T, Konishi M, Iso H (2010) Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS). Diabetologia 53(3):481–488. doi:10.1007/s00125-009-1616-0
6. Ailhaud G (2006) Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome. C R Biol 329 (8):570-577, 653-655. doi:10.1016/j.crvi.2005.12.012
7. Al MS, Mojiminiyi OA, Al AA, Al RT, Abdella N (2014) Study of leptin and adiponectin as disease markers in subjects with obstructive sleep apnea. Dis Markers 2014:706314. doi:10.1155/2014/706314
8. Diogo LN, Monteiro EC (2014) The efficacy of antihypertensive drugs in chronic intermittent hypoxia conditions. Front Physiol 5:361. doi:10.3389/fphys.2014.00361
9. Wang X, Liang L, Junfen FU, Lizhong DU (2007) Metabolic syndrome in obese children born large for gestational age. Indian J Pediatr 74(6):561–565
10. Ben Y, Chen J, Zhu R, Gao L, Bai C (2008) Upregulation of AQP3 and AQP5 induced by dexamethasone and ambroxol in A549 cells. Respir Physiol Neurobiol 161(2):111–118. doi:10.1016/j.resp.2007.12.007
11. Chen L, Cao ZL, Han F, Gao ZC, He QY (2010) Chronic intermittent hypoxia from pedo-stage decreases glucose transporter 4 expression in adipose tissue and causes insulin resistance. Chin Med J (Engl) 123(4):463–470
12. Matsuzawa Y, Funahashi T, Nakamura T (1999) Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci 892:146–154
13. Varady KA, Tussing L, Bhutani S, Braunschweig CL (2009) Degree of weight loss required to improve adipokine concentrations and decrease fat cell size in severely obese women. Metabolism 58(8):1096–1101. doi:10.1016/j.metabol.2009.04.010
14. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Et A (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334(5):292–295. doi:10.1056/NEJM199602013340503
15. Vidal H, Auboeuf D, De Vos P, Staels B, Riou JP, Auwerx J, Laville M (1996) The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. J Clin Invest 98(2):251–255. doi:10.1172/JCI118786
16. Vazquez-Vela ME, Torres N, Tovar AR (2008) White adipose tissue as endocrine organ and its role in obesity. Arch Med Res 39(8):715–728. doi:10.1016/j.arcmed.2008.09.005
17. Jain SH, Massaro JM, Hoffmann U, Rosito GA, Vasan RS, Raji A, O'Donnell CJ, Meigs JB, Fox CS (2009) Cross-sectional associations between abdominal and thoracic adipose tissue compartments and adiponectin and resistin in the Framingham Heart Study. Diabetes Care 32:903–908
18. Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A, Saruta T (2003) Correlation between serum resistin level and adiposity in obese individuals. Obes Res 11(8):997–1001. doi:10.1038/oby.2003.137
19. Vong L, Ye C, Yang Z, Choi B, Chua SJ, Lowell BB (2011) Leptin action on GABAergic neurons prevents obesity and reduces inhibitory tone to POMC neurons. Neuron 71(1):142–154. doi:10.1016/j.neuron.2011.05.028
20. Menzaghi C, Ercolino T, Di Paola R, Berg AH, Warram JH, Scherer PE, Trischitta V, Doria A (2002) A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51(7):2306–2312
21. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Et A (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1(11):1155–1161
22. Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM (2002) The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51(10):2968–2974
23. Wang B, Wood IS, Trayhurn P (2007) Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch 455(3):479–492. doi:10.1007/s00424-007-0301-8
24. Ye J, Gao Z, Yin J, He Q (2007) Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293(4):E1118–E1128. doi:10.1152/ajpendo.00435.2007
25. Chen B, Lam KS, Wang Y, Wu D, Lam MC, Shen J, Wong L, Hoo RL, Zhang J, Xu A (2006) Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. Biochem Biophys Res Commun 341(2):549–556. doi:10.1016/j.bbrc.2006.01.004
26. Wiesner G, Brown RE, Robertson GS, Imran SA, Ur E, Wilkinson M (2006) Increased expression of the adipokine genes resistin and fasting-induced adipose factor in hypoxic/ischaemic mouse brain. Neuroreport 17(11):1195–1198. doi:10.1097/01.wnr.0000224776.12647.ba
27. Wang B, Wood IS, Trayhurn P (2008) Hypoxia induces leptin gene expression and secretion in human preadipocytes: differential effects of hypoxia on adipokine expression by preadipocytes. J Endocrinol 198(1):127–134. doi:10.1677/JOE-08-0156
28. Bedessem B, Stephanou A (2014) Role of compartmentalization on HiF-1alpha degradation dynamics during changing oxygen conditions: a computational approach. PLoS One 9(10):e110495. doi:10.1371/journal.pone.0110495
29. Semenza G (2002) Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 64(5–6):993–998